Alkindi®
Pediatric-Adapted Therapy for Adrenal Insufficiency
Efmody®
Treatment for Congenital Adrenal Hyperplasia
Miglustat Dipharma®
Oral Treatment for Gaucher Disease and Niemann-Pick Type C
Niemann-Pick Disease Type C
Congenital Adrenal Hyperplasia
Adrenal Insufficiency
Osteoporosis
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Lupin for Commercialization of BINOSTO® in Vietnam & Philippines
Freienbach, February 6, 2024 – EffRx Pharmaceuticals SA, a commercial-stage pharmaceutical company focused on the development and commercialization of musculoskeletal and rare diseases medications, today announced
EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO® In The United States
Freienbach, September 19th, 2023 – EffRx Pharmaceuticals SA, a commercial-stage pharmaceutical company focused on the development and commercialization of musculoskeletal and rare diseases medications, today announced
World Orphan Drug Alliance (WODA) Marks their First Anniversary
News World Orphan Drug Alliance (WODA) Marks their First Anniversary July 12, 2023 World Orphan Drug Alliance (WODA) Marks their First Anniversary Read more Contact Wolleraustrasse 41B, 8807 Freienbach, Switzerland +41 44 503 78 60 info@effrx.com SHARE THIS ARTICLE